Back to CS Candriam S.C.A.
ADPT
Showing 2 of 5 quarters
Position history for CSCandriam S.C.A.'s holdings in ADAPTIVE BIOTECHNOLOGIES
No. Candriam S.C.A. exited its ADPT (Adaptive Biotechnologies) position in Q2 2025. Its Q1 2025 13F listed 12,058 shares worth $89,591. Candriam S.C.A. first reported ADPT in Q3 2022 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$89,591
Total Shares Change
-12,058
Quarter-by-Quarter History